USD 1.0
(-4.76%)
Year | Net Income | Net Income Growth |
---|---|---|
2024 | -123.33 USD | 99.91% |
2023 | -140.66 Thousand USD | 80.5% |
2022 | -721.4 Thousand USD | 69.45% |
2021 | -2.36 Million USD | -553.27% |
2020 | -361.5 Thousand USD | -16520.87% |
2019 | -2175.00 USD | -0.0% |
2018 | -2175.00 USD | 0.0% |
2014 | -616.18 Thousand USD | -7344.56% |
2013 | -8277.00 USD | -341642.36% |
2012 | -2.42 USD | 0.0% |
Year | Net Income | Net Income Growth |
---|---|---|
2024 Q2 | -9860.00 USD | 31.57% |
2024 Q3 | -14.2 Thousand USD | -44.05% |
2024 Q4 | -84.81 Thousand USD | -497.13% |
2024 Q1 | -14.4 Thousand USD | -2598.31% |
2024 FY | -123.32 Thousand USD | 12.32% |
2023 Q1 | -123.42 Thousand USD | 100.0% |
2023 Q2 | -4362.00 USD | 96.47% |
2023 Q4 | -534.00 USD | 95.67% |
2023 FY | -140.66 Thousand USD | 80.5% |
2023 Q3 | -12.32 Thousand USD | -182.49% |
2022 Q4 | -48.19 Billion USD | -96211666.32% |
2022 FY | -721.4 Thousand USD | 69.45% |
2022 Q3 | 50.09 Thousand USD | 126.65% |
2022 Q2 | -187.93 Thousand USD | 57.0% |
2022 Q1 | -437.04 Thousand USD | 37.93% |
2021 FY | -2.36 Million USD | -553.27% |
2021 Q4 | -704.16 Thousand USD | -5.53% |
2021 Q3 | -667.28 Thousand USD | -5.87% |
2021 Q1 | -322.23 Thousand USD | -139.8% |
2021 Q2 | -630.28 Thousand USD | -95.6% |
2020 Q2 | -11.7 Thousand USD | 35.61% |
2020 FY | -361.5 Thousand USD | -16520.87% |
2020 Q4 | -134.37 Thousand USD | 31.01% |
2020 Q3 | -194.76 Thousand USD | -1563.82% |
2020 Q1 | -18.18 Thousand USD | 0.0% |
2019 FY | -2175.00 USD | -0.0% |
2018 FY | -2175.00 USD | 0.0% |
2015 Q2 | -892.22 Thousand USD | 21.94% |
2015 Q1 | -1.14 Million USD | -87.95% |
2015 Q3 | -900.18 Thousand USD | -0.89% |
2014 Q4 | -608.17 Thousand USD | -212748.25% |
2014 FY | -616.18 Thousand USD | -7344.56% |
2014 Q3 | 286.00 USD | 108.79% |
2014 Q2 | -3254.00 USD | 35.49% |
2014 Q1 | -5044.00 USD | -112.83% |
2013 Q4 | -2370.00 USD | 0.29% |
2013 Q3 | -2377.00 USD | 27.35% |
2013 Q2 | -3272.00 USD | -1163.32% |
2013 FY | -8277.00 USD | -341642.36% |
2013 Q1 | -259.00 USD | -64008.91% |
2012 Q4 | -0.40 USD | 0.0% |
2012 FY | -2.42 USD | 0.0% |
Name | Net Income | Net Income Difference |
---|---|---|
GSRX Industries Inc. | - USD | Infinity% |
High Sierra Technologies, Inc. | -323.95 Thousand USD | 99.962% |
Instadose Pharma Corp. | - USD | Infinity% |